Trials / Unknown
UnknownNCT00125996
Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure
A Randomised Controlled Study to Assess the Acute and Chronic Effects of Intravenous Iron Supplementation in Anaemic and Non-Anaemic Iron Deficient Patients With Chronic Heart Failure
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 42 (planned)
- Sponsor
- National Heart and Lung Institute · Academic / Other
- Sex
- All
- Age
- 30 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
This is a two-center, randomised, single-blind (physician), prospective, controlled study to assess the acute (8 weeks) and chronic (16 weeks) effects of intravenous (IV) iron sucrose supplementation in anaemic and non-anaemic iron deficient patients with chronic heart failure (CHF). The hypotheses are: * Treatment of anaemic and non-anaemic iron-deficient CHF patients with IV iron sucrose improves exercise capacity as measured by peak VO2. * IV iron sucrose is safe and well tolerated in subjects with moderate to severe CHF.
Detailed description
Study Phase and Design: Prospective two-centre, randomized, controlled, open-label, observer-blinded, parallel-group study Primary Objective: To evaluate the effect of intravenous (IV) iron supplementation on exercise tolerance, as determined by peak VO2. Secondary Objectives: * To evaluate the effects of IV iron supplementation on exercise duration, left ventricular (LV) structure and function, symptom status (NYHA class, Minnesota Living with Heart Failure Questionnaire \[MLHFQ\], and subjective fatigue score), and haematological and biochemical (haemoglobin \[Hb\], haematocrit \[Hct\], iron status, N-BNP, cytokines and oxidative stress) indices. * To evaluate the safety profile of IV iron in subjects with moderate to severe CHF. Sample Size: 42 subjects (28 IV iron, 14 placebo); 50% anaemic and 50% non-anaemic
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Venofer (intravenous iron sucrose) |
Timeline
- Start date
- 2004-07-01
- Completion
- 2006-02-01
- First posted
- 2005-08-02
- Last updated
- 2005-08-17
Locations
2 sites across 2 countries: Poland, United Kingdom
Source: ClinicalTrials.gov record NCT00125996. Inclusion in this directory is not an endorsement.